Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34(cdc2) kinase

The induction of tumor cell death by anticancer therapy results from a genetic program of autonomous cell death termed apoptosis. Because the p53 tumor suppressor gene is a critical component for induction of apoptosis in response to DNA damage, its inactivation in cancers may be responsible for their resistance to genotoxic anticancer agents. The cellular response to DNA damage involves a cell-cycle arrest at both the G₁/S and G₂/M transitions; these checkpoints maintain viability by preventing the replication or segregation of damaged DNA, the arrest at the G₁ checkpoint is mediated by p53-dependent induction of p21(WAF1/CIP1), whereas the G₂ arrest involves inactivation of p34(cdc2) kinase. Following DNA damage, p53-deficient cells fail to arrest at G₁ and accumulate at the G₂/M transition. We demonstrate that abrogation of G₂ arrest by caffeine-mediated activation of p34(cdc2) kinase results in the selective sensitization of p53-deficient primary and tumor cells to irradiation-induced apoptosis. These data suggest that pharmacologic activation of p34(cdc2) kinase may be a useful therapeutic strategy for circumventing the resistance of p53-deficient cancers to genotoxic anticancer agents.